V025-2936 Screening compound: 4-[3-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1-[(2-methoxyphenyl)methyl]-2-methylpiperazine

V025-2936 Screening compound: 4-[3-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1-[(2-methoxyphenyl)methyl]-2-methylpiperazine
V025-2936 Screening compound: 4-[3-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1-[(2-methoxyphenyl)methyl]-2-methylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2936
4-[3-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1-[(2-methoxyphenyl)methyl]-2-methylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2936

Molecular Formula

C29H30N6O2 (C29 H30 N6 O2)

Compound Name

4-[3-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-1-[(2-methoxyphenyl)methyl]-2-methylpiperazine

IUPAC name

4-[3-(4-methoxyphenyl)-[124]triazolo[43-c]quinazolin-5-yl]-1-[(2-methoxyphenyl)methyl]-2-methylpiperazine

SMILES

CC(C1)N(Cc(cccc2)c2OC)CCN1c1nc(cccc2)c2c2nnc(-c(cc3)ccc3OC)n12

InChI

InChI=1S/C29H30N6O2/c1-20-18-34(17-16-33(20)19-22-8-4-7-11-26(22)37-3)29-30-25-10-6-5-9-24(25)28-32-31-27(35(28)29)21-12-14-23(36-2)15-13-21/h4-15,20H,16-19H2,1-3H3/t20-/m0/s1

InChI Key

NMJPZIXTUZYDNQ-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD19924377

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

494.6

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.173

Distribution Coefficient, logD

4.625

Water Solubility, LogSw

-5.35

Polar Surface Area

51.092

Acid Dissociation Constant (pKa)

20.82

Base Dissociation Constant (pKb)

7.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

27.60

V025-2936 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with V025-2936 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2936?
Check Price and Availability of V025-2936, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2936 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2936
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2936
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2936 available by request